Results

Total Results: 1,569 records

Showing results for "discussed".

  1. effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
    June 09, 2021 - In addition, the key questions listed demonstrate the main points discussed in the entire report. … Reviewer #1 Results Page 56-57 of 280 Serious adverse events- Please include citations for the studies discussed … 57 of 280 No. of adverse events and Radiation necrosis- Please include citations for the studies discussed … Peer Reviewer #1 Results Page 57-58 of 280 Headaches- Please include citations for the studies discussed … #1 Results Page 59 of 280 Fatigue, Seizure, Vomiting- Please include citations for the studies discussed
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - Comparisons with prior reviews are concisely and clearly discussed. … The mentioned reviews and others are Discussed for contextual purposes. … I would also recommend consistency in the report in the order in which these are discussed. … This association is not intuitive and is not commonly discussed. … The results of the American Pain Society review are discussed throughout the report.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - don’t think you necessarily need to change the inclusion criteria at this point, but this should be discussed … As discussed there is sparse data evaluating direct comparisons. 118. … The study by Hijazi was included in our report and is discussed in the subgroup table within KQ3. … rivaroxaban for nonvalvular AF;” however BI notes that data from Gorst-Rasmussen et al. (2016) is not discussed … Peer Reviewer #5 Clarity/ Usability See general comments (#s 24-36) No response needed – discussed
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
    March 15, 2016 - ES-2, line 15: Regarding the management that is discussed about gout (as opposed to “chronic gout”). … The IL-1 antagonists should be discussed as the treatments for gout; they are not used to lower urate … TEP Reviewer #3 Results Full Report:• Page 34 of 176: IL-1B antagonists should not be discussed under … management of hyperuricemia; they should be discussed under management of gout attacks. … I believe that this is what rheumatologists and the FDA have been doing as discussed above.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-mobile-devices_research-protocol.pdf
    July 12, 2017 - As discussed in the previous section, we will use a hierarchical approach to reviewing the evidence, … These challenges will be discussed with key informants and other topic experts to identify which challenges
  6. Politi (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
    May 29, 2025 - Politi Slide  1: Supporting  Shared Decisions When Clinical Evidence  is Low Mary C. Politi, Ph.D. Department of Surgery, Division of  Public Health Sciences Washington University in St. Louis School of Medicine Slide  2: Overview • Brief overview of Shared Decis…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
    August 23, 2013 - We have discussed this potential limitation in the Discussion section. … It seems like in the conclusions harms of newer antithrombotics were not really discussed, in particular … Thank you for this comment; we agree that the INR control discussed in this statement refers to center-based … TEP #3 Methods Generally OK Page 18, last para - limitations of c-statistics should be discussed, … This should be discussed We have noted that CHA2DS2-VASc is used more commonly in Europe and has been
  8. effectivehealthcare.ahrq.gov/sites/default/files/cer-237-integrating-palliative-care-disposition-comments.pdf
    February 11, 2021 - interdisciplinary approach to care, which did not appear to come through in most of the studies discussed
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
    May 01, 2014 - Web-based collaborative forum” reflects the broader concept of a “community of practice” (CoP), as discussed … Having found that a need for a CoP existed, stakeholders then discussed the value that they would draw … These issues are summarized below, and are discussed in more detail in the Recommendations section of … Finally, a Web site can offer concrete tools, which are discussed further in the subsequent sections … If the funding structure or governance of the Web-based CoP discussed in this report includes AHRQ,
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
    June 05, 2013 - Summary Need to discuss adverse events by surgical procedure as they differ Adverse events are discussed … Peer Reviewer 5 Methods It looks like individual drug and lifestyle studies were only discussed in … Blood pressure, cholesterol, and QOL from the O’Brien study are discussed in the accompanying text. … The appropriate literature is concluded, and discussed. … This issue is discussed in the applicability section.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
    January 01, 2013 - Community Forum: Introduction to Online Tools To Support Public Deliberation This presentation introduces online tools that can be used to support public deliberation. During this presentation, we discuss the types of online tools that can be used to support public deliberation and what to consider when select…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
    June 16, 2022 - Disposition of Comments_Comparative Effectiveness Review No. 256: Effectiveness of Telehealth for Women's Preventive Services Comparative Effectiveness Review Disposition of Comments Report Title: Effectiveness of Telehealth for Women’s Preventive Services Draft report available for public comment…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_disposition-comments.pdf
    January 26, 2015 - Outcomes for men (vs. women) are discussed on page 18 of the report under Results by Sex. … Looking only at the psychological treatments, only 4 studies could be discussed. … questions are truely important, a case for answering the questions should be made and the lack of data discussed … conclusions about the equivicality of need for more intensive care for subgroups cannot be reliably discussed
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-disposition-comments.pdf
    June 28, 2022 - changes to the schedule of visits and televisits for routine antenatal care need to be more prominently discussed
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - This was discussed with the TEP and is admittedly a trade-off. … This point was discussed with the TEP, who agreed that limiting to live birth was appropriate; we have … Jessica Goldstein (Public Reviewer #1) Results Elective single-embryo transfer (eSET) discussed in
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/scarce-resources-protocol.pdf
    January 01, 2013 - of the findings was assessed, and (5) potential confounders to the strategy’s effectiveness were discussed
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
    May 22, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 260: Nutrition as Prevention for Improved Cancer Health Outcomes Comparative Effectiveness Review Disposition of Comments Report Title: Nutrition as Prevention for Improved Cancer Health Outcomes Draft report available for public comment…
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
    September 10, 2012 - reported under KQ1b and also included in the discussion, where addition certification issues are discussed … Added text to Methods to clarify that these results are discussed under kq1b and 2b. … Reviewer 2 Summary and Discussion The limitations discussed were right on target.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_disposition-comments.pdf
    March 01, 2012 - give the reader an overview of the trials which were summarize quantitatively separately from those discussed … might object to the use of random effects model – see AHRQs guidance for rare events This topic was discussed
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-disposition-comments.pdf
    August 29, 2023 - The EPC sought clarification on the requests and discussed them with ASTRO.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: